S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Laser breakthrough could send stock soaring 2,467% (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Is New IPO Instacart Already Hitting Speed Bumps?
30 Days of MarketBeat All Access Free (Ad)
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Laser breakthrough could send stock soaring 2,467% (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Is New IPO Instacart Already Hitting Speed Bumps?
30 Days of MarketBeat All Access Free (Ad)
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Laser breakthrough could send stock soaring 2,467% (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Is New IPO Instacart Already Hitting Speed Bumps?
30 Days of MarketBeat All Access Free (Ad)
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Laser breakthrough could send stock soaring 2,467% (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Is New IPO Instacart Already Hitting Speed Bumps?
30 Days of MarketBeat All Access Free (Ad)
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
NYSE:AMPE

Ampio Pharmaceuticals (AMPE) Stock Forecast, Price & News

$4.10
-0.01 (-0.24%)
(As of 09/22/2023 ET)
Compare
Today's Range
$4.03
$4.26
50-Day Range
$0.26
$5.08
52-Week Range
$3.35
$23.73
Volume
15,721 shs
Average Volume
20,002 shs
Market Capitalization
$3.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

AMPE stock logo

About Ampio Pharmaceuticals (NYSE:AMPE) Stock

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprietary, small molecule formulation for the treatment of osteoarthritis of the knee. The company is headquartered in Englewood, Colorado.

AMPE Price History

AMPE Stock News Headlines

StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)
Is NVIDIA Leading a "Magnificent Seven Bubble"?
The world’s massive tech leaders may be in a bubble, led by NVIDIA’s enormous rise this year. What happens next could affect all stocks. 
Ampio Pharmaceuticals Board Approves Reverse Stock Split - Quick Facts
Ampio Pharmaceuticals Announces Reverse Stock Split
6.5 Million Americans Are DESPERATE for This New Drug from One Tiny Company
Decades of pent-up demand for this "first-ever" treatment could give you WINDFALL PROFITS... Click here to learn more >>>
AMPE - Ampio Pharmaceuticals, Inc.
See More Headlines
Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMPE Company Calendar

Last Earnings
8/08/2023
Today
9/22/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Employees
8
Year Founded
N/A

Profitability

Net Income
$-16,340,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$15.62 per share

Miscellaneous

Free Float
730,000
Market Cap
$3.09 million
Optionable
Optionable
Beta
1.78
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Michael A. Martino (Age 66)
    CEO & Director
    Comp: $548.14k
  • Dr. David Bar-Or M.D. (Age 74)
    Founder & Chairman of Scientific Advisory Board
    Comp: $145.6k
  • Mr. Daniel G. Stokely CPA (Age 59)
    CPA, CFO, Corp. Sec. & Treasurer
    Comp: $346.73k
  • Dr. Howard Levy M.B.B.Ch. (Age 69)
    M.M.M., Ph.D., Chief Medical Officer
  • April Ramirez
    Clinical Trial Mang.













AMPE Stock - Frequently Asked Questions

How have AMPE shares performed in 2023?

Ampio Pharmaceuticals' stock was trading at $4.5040 at the beginning of 2023. Since then, AMPE shares have decreased by 9.1% and is now trading at $4.0950.
View the best growth stocks for 2023 here
.

Are investors shorting Ampio Pharmaceuticals?

Ampio Pharmaceuticals saw a increase in short interest in the month of August. As of August 15th, there was short interest totaling 416,200 shares, an increase of 51.7% from the July 31st total of 274,300 shares. Based on an average daily volume of 439,300 shares, the days-to-cover ratio is currently 0.9 days. Approximately 3.1% of the company's shares are sold short.
View Ampio Pharmaceuticals' Short Interest
.

When is Ampio Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our AMPE earnings forecast
.

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) posted its quarterly earnings data on Tuesday, August, 8th. The company reported ($1.80) earnings per share (EPS) for the quarter.

When did Ampio Pharmaceuticals' stock split?

Ampio Pharmaceuticals shares reverse split before market open on Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Tesla (TSLA), Agenus (AGEN) and American Airlines Group (AAL).

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the New York Stock Exchange (NYSE) under the ticker symbol "AMPE."

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $4.10.

How much money does Ampio Pharmaceuticals make?

Ampio Pharmaceuticals (NYSE:AMPE) has a market capitalization of $3.09 million. The company earns $-16,340,000.00 in net income (profit) each year or ($20.60) on an earnings per share basis.

How can I contact Ampio Pharmaceuticals?

Ampio Pharmaceuticals' mailing address is 373 Inverness Parkway, Suite 200, Englewood, CO 80112, United States. The official website for the company is ampiopharma.com. The company can be reached via phone at 720-437-6500, via email at info@ampiopharma.com, or via fax at 720-437-6501.

This page (NYSE:AMPE) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -